BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27143146)

  • 1. Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based Study.
    Vidaver RM; Shershneva MB; Hetzel SJ; Holden TR; Campbell TC
    J Oncol Pract; 2016 Jun; 12(6):e643-53. PubMed ID: 27143146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment.
    Ezer N; Navasakulpong A; Schwartzman K; Ofiara L; Gonzalez AV
    BMC Pulm Med; 2017 Dec; 17(1):178. PubMed ID: 29216855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
    Vinod SK; Chandra A; Berthelsen A; Descallar J
    Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timeliness of lung cancer diagnosis and treatment: a single-center experience.
    Rao SS; Saha S
    Asian Cardiovasc Thorac Ann; 2019 Oct; 27(8):670-676. PubMed ID: 31569945
    [No Abstract]   [Full Text] [Related]  

  • 5. Delays in the diagnosis and treatment of lung cancer.
    Salomaa ER; Sällinen S; Hiekkanen H; Liippo K
    Chest; 2005 Oct; 128(4):2282-8. PubMed ID: 16236885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study.
    Forrest LF; Adams J; White M; Rubin G
    Br J Cancer; 2014 Oct; 111(9):1843-51. PubMed ID: 25203519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer.
    Giroux Leprieur E; Labrune S; Giraud V; Gendry T; Cobarzan D; Chinet T
    Clin Lung Cancer; 2012 Sep; 13(5):363-8. PubMed ID: 22264658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timeliness of lung cancer care in Victoria: a retrospective cohort study.
    Evans SM; Earnest A; Bower W; Senthuren M; McLaughlin P; Stirling R
    Med J Aust; 2016 Feb; 204(2):75. PubMed ID: 26821108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delays during the diagnostic evaluation and treatment of lung cancer.
    Chandra S; Mohan A; Guleria R; Singh V; Yadav P
    Asian Pac J Cancer Prev; 2009; 10(3):453-6. PubMed ID: 19640190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timeliness across the continuum of care in veterans with lung cancer.
    Powell AA; Schultz EM; Ordin DL; Enderle MA; Graham BA; Partin MR; Gould MK
    J Thorac Oncol; 2008 Sep; 3(9):951-7. PubMed ID: 18758295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell lung cancer: time to diagnosis and treatment.
    Haque N; Raza A; McGoey R; Boulmay B; Diethelm L; Kantrow S
    South Med J; 2012 Aug; 105(8):418-23. PubMed ID: 22864099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waiting Time Intervals for Non-small Cell Lung Cancer Diagnosis and Treatment in Alberta: Quantification of Intervals and Identification of Risk Factors Associated with Delays.
    Kim JO; Davis F; Butts C; Winget M
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):750-759. PubMed ID: 27357099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wait times in diagnostic evaluation and treatment for patients with stage III non-small cell lung cancer in British Columbia.
    Wai ES; Mackinnon M; Hooker R; Moccia P; Perry KR; Truong PT
    Am J Clin Oncol; 2012 Aug; 35(4):373-7. PubMed ID: 21422900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timeliness of care in veterans with non-small cell lung cancer.
    Gould MK; Ghaus SJ; Olsson JK; Schultz EM
    Chest; 2008 May; 133(5):1167-73. PubMed ID: 18263676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study.
    Forrest LF; Adams J; Rubin G; White M
    Thorax; 2015 Feb; 70(2):138-45. PubMed ID: 24923873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review.
    Jacobsen MM; Silverstein SC; Quinn M; Waterston LB; Thomas CA; Benneyan JC; Han PKJ
    Lung Cancer; 2017 Oct; 112():156-164. PubMed ID: 29191588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of patients presenting to a dedicated rapid access lung cancer clinic.
    Dunican E; Uzbeck M; Clince J; Toner S; Royston D; Logan MP; Breathnach O; Young V; Linnane SI; Morgan RK
    Ir Med J; 2011 Oct; 104(9):265-8. PubMed ID: 22132593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care.
    Kehl KL; Landrum MB; Arora NK; Ganz PA; van Ryn M; Mack JW; Keating NL
    JAMA Oncol; 2015 Apr; 1(1):50-8. PubMed ID: 26182303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why do some lung cancer patients receive no anticancer treatment?
    Vinod SK; Sidhom MA; Gabriel GS; Lee MT; Delaney GP
    J Thorac Oncol; 2010 Jul; 5(7):1025-32. PubMed ID: 20453689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis.
    Lo DS; Zeldin RA; Skrastins R; Fraser IM; Newman H; Monavvari A; Ung YC; Joseph H; Downton T; Maxwell L; Meharchand J
    J Thorac Oncol; 2007 Nov; 2(11):1001-6. PubMed ID: 17975490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.